GTI-2040
L01-1409
Phase 2 small_molecule completed
Quick answer
GTI-2040 for Carcinoma, Renal Cell is a Phase 2 program (small_molecule) at Aptose Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptose Biosciences
- Indication
- Carcinoma, Renal Cell
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed